JSPR
Jasper Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.71
+3.23%Next report
Analyst consensus
- Next report date
- Nov 9, 2026
- EPS estimate
- -$0.08
- Revenue estimate
- $12.0M
Latest reported
- Last report date
- Aug 14, 2026
- EPS actual
- -$0.10
- EPS estimate
- -$0.27
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 6
- EPS misses (12Q)
- 6
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +23.6%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 9, 2026